Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NNOX
NNOX logo

NNOX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.910
Open
1.770
VWAP
1.86
Vol
1.17M
Mkt Cap
125.96M
Low
1.770
Amount
2.18M
EV/EBITDA(TTM)
--
Total Shares
69.59M
EV
63.92M
EV/OCF(TTM)
--
P/S(TTM)
8.61
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Show More

Events Timeline

(ET)
2026-04-23
09:10:00
Nano-X Imaging Signs Distribution Agreement with Radiology Oncology Systems
select
2026-04-20 (ET)
2026-04-20
16:30:00
Major Averages Decline Amid Escalating Tensions with Iran
select
2026-04-20
12:00:00
Major Averages Decline Amid Rising Tensions with Iran
select
2026-04-20
09:00:00
U.S. Stock Futures Decline Amid Rising Tensions with Iran
select
2026-04-20
08:50:00
Company Restructures to Align Manufacturing Costs with Financial Model
select
2026-04-20
08:40:00
Q1 Revenue at $3.72M, Below Consensus of $3.99M
select
2026-04-20
08:40:00
Nano-X Imaging Expects Revenue Growth to Depend on System Activation Timing
select
2026-04-20
08:40:00
CFO Ran Daniel Announces Resignation
select

News

PRnewswire
7.0
19:56 PMPRnewswire
Investigation Launched into Nano-X Imaging for Securities Fraud
  • Financial Loss Disclosure: Nano-X Imaging reported a net loss of $33.4 million for Q4 2025 in its April 20, 2026 press release, primarily due to a $17.5 million charge for impairment of long-lived assets following a restructuring at its Korean chip manufacturing facility, indicating significant financial strain during business adjustments.
  • Executive Changes: The company announced that CFO Ran Daniel will step down on July 31, 2026, which may undermine investor confidence in the company's future financial management and exacerbate market uncertainty.
  • Stock Price Plunge: Following the earnings report, Nano-X's stock price fell by $0.70, a 24.39% drop, closing at $2.16 per share, reflecting investor concerns regarding the company's financial health and future outlook.
  • Legal Investigation Initiated: Pomerantz LLP is investigating whether Nano-X and its executives engaged in securities fraud or other unlawful business practices, which could expose the company to legal liabilities and potential damages, further impacting its market performance.
NASDAQ.COM
2.0
16:03 PMNASDAQ.COM
Nano-X Imaging (NNOX) Q4 2025 Earnings Transcript
PRnewswire
7.0
05-15PRnewswire
Pomerantz LLP Investigates Claims for Nano-X Investors
  • Financial Loss Disclosure: Nano-X reported a net loss of $33.4 million for Q4 2025 in its April 20, 2026 press release, primarily due to a $17.5 million impairment charge from restructuring its Korean chip manufacturing facility, indicating significant financial strain during its transition.
  • Executive Change Impact: The announcement that CFO Ran Daniel will resign on July 31, 2026, raises concerns among investors regarding the company's future financial management capabilities, potentially undermining market confidence and affecting stock performance.
  • Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.70, or 24.39%, closing at $2.16 per share, reflecting a strong negative market reaction to the company's financial condition and outlook.
  • Legal Investigation Initiated: Pomerantz LLP is investigating whether Nano-X and its executives engaged in securities fraud or other unlawful business practices, which could expose the company to class action risks and further exacerbate investor anxiety.
Globenewswire
3.5
05-13Globenewswire
MindBio Leverages AI Voice Analysis for Impairment Detection
  • Technological Innovation: MindBio Therapeutics is developing a platform that combines AI and voice analysis to detect impairment from multiple substances in real-time, addressing a significant gap in existing detection technologies and potentially enhancing public safety and health response capabilities.
  • Market Potential: The company targets a market of approximately $47 billion in workplace safety and substance testing, aiming to drive industry efficiency and compliance through the application of non-invasive detection technologies to meet growing market demands.
  • Scientific Basis: MindBio's technology is grounded in clinical trial data from over 50 million data points, enabling efficient identification of impairment signatures from various substances, providing a more comprehensive assessment than traditional single-substance tests, which holds significant clinical and societal implications.
  • Industry Impact: By facilitating real-time impairment detection, MindBio's technology could reduce traffic and workplace accidents, enhancing overall societal safety, aligning with the global urgent need for rapid, scalable detection solutions.
Newsfilter
3.5
05-13Newsfilter
MindBio Leverages AI Voice Analysis for Impairment Detection
  • Technological Innovation: MindBio Therapeutics is developing a platform that combines AI and voice analysis to detect impairment from multiple substances in real-time, addressing a significant gap in existing detection technologies and is expected to greatly enhance public and workplace safety.
  • Market Potential: The company is targeting a market of approximately $47 billion in workplace safety and substance testing, with growing demand for efficient and scalable detection solutions, positioning MindBio's technology for widespread application across various industries.
  • Scientific Foundation: MindBio's technology is grounded in clinical trial data from over 50 million data points, enabling efficient identification of intoxication states and providing a more comprehensive assessment compared to traditional single-substance tests, with high detection accuracy.
  • Social Impact: By reducing traffic accidents and workplace incidents caused by intoxication, MindBio's non-invasive detection methods have the potential to improve public health globally and lower the societal costs associated with substance use.
Globenewswire
7.0
05-12Globenewswire
Investigation Launched into Nano-X Imaging for Securities Fraud
  • Financial Loss Disclosure: Nano-X reported a net loss of $33.4 million for Q4 2025 in its April 20, 2026 press release, primarily due to a $17.5 million impairment charge related to restructuring at its Korean chip manufacturing facility, indicating significant financial strain during its transition.
  • Executive Departure Impact: CFO Ran Daniel's announcement to step down on July 31, 2026, raises concerns among investors regarding the company's future financial management capabilities, potentially undermining market confidence and affecting stock performance.
  • Stock Price Volatility: Following the earnings report, Nano-X's stock price fell by $0.70, or 24.39%, closing at $2.16 per share, reflecting a strong negative market reaction to the company's financial condition and outlook.
  • Legal Investigation Initiated: Pomerantz LLP is investigating whether Nano-X and its executives engaged in securities fraud or other unlawful business practices, which could lead to a class action lawsuit and further exacerbate investor anxiety.
Wall Street analysts forecast NNOX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NNOX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Current: 0.000
sliders
Low
7.00
Averages
7.00
High
7.00
Alliance Global
Buy
to
Buy
downgrade
$7 -> $5
AI Analysis
2026-04-22
Reason
Alliance Global
Price Target
$7 -> $5
AI Analysis
2026-04-22
downgrade
Buy
to
Buy
Reason
Alliance Global lowered the firm's price target on Nano-X Imaging to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were within the firm's expectations, with the main points of the print including that the quarter was in-line with AGP forecasts, management maintained 2026 revenue guidance, implying a significant upward breakout from current trends, and the company highlighting recent distribution agreements, the analyst tells investors in a research note. The firm added that it remains more conservative pending data points of execution.
Alliance Global Partners
Buy
downgrade
$9 -> $7
2025-05-22
Reason
Alliance Global Partners
Price Target
$9 -> $7
2025-05-22
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Nano-X Imaging to $7 from $9 and keeps a Buy rating on the shares. The firm cites the company's Q1 revenue missing forecasts, suggesting a challenging macro environment, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NNOX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nano-X Imaging Ltd (NNOX.O) is 0.00, compared to its 5-year average forward P/E of -9.91. For a more detailed relative valuation and DCF analysis to assess Nano-X Imaging Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.91
Current PE
0.00
Overvalued PE
-4.53
Undervalued PE
-15.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.15
Current EV/EBITDA
-0.30
Overvalued EV/EBITDA
6.94
Undervalued EV/EBITDA
-9.23

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
218.88
Current PS
2.10
Overvalued PS
987.12
Undervalued PS
-549.35

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

create swing trade setup
Intellectia · 358 candidates
Price: $1.00 - $5.00List Exchange: XNAS, XNYS, XASEMoving Average Relationship: PriceAboveMA20, PriceBelowMA5, PriceBelowMA10Week Price Change Pct: $-10.00 - $10.00Macd: bullish, positive
Ticker
Name
Market Cap$
top bottom
TCRT logo
TCRT
Alaunos Therapeutics Inc
7.60M
OSTX logo
OSTX
OS Therapies Inc
53.17M
NNOX logo
NNOX
Nano-X Imaging Ltd
169.34M
FLNT logo
FLNT
Fluent Inc
107.58M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
685.30M
MRT logo
MRT
Marti Technologies Inc
175.91M
Give me something more volatile
Intellectia · 18 candidates
Market Cap: 30.00M - 1000.00MPrice: $0.50 - $25.00Price Change Pct: >= $5.00Beta: HighRiskWeek Price Change Pct: >= $3.00
Ticker
Name
Market Cap$
top bottom
PSFE logo
PSFE
Paysafe Ltd
428.67M
KZIA logo
KZIA
Kazia Therapeutics Ltd
113.47M
ACVA logo
ACVA
ACV Auctions Inc
964.36M
SABR logo
SABR
Sabre Corp
711.30M
LAW logo
LAW
CS Disco Inc
248.88M
AENT logo
AENT
Alliance Entertainment Holding Corp
316.45M
what stock under $5 should I buy today?
Intellectia · 56 candidates
Market Cap: >= 100.00MRegion: USPrice: $0.50 - $5.00Quarter Revenue Yoy Growth: >= 5.0%List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
API logo
API
Agora Inc
431.16M
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.58B
GOGO logo
GOGO
Gogo Inc
599.67M
IMPP logo
IMPP
Imperial Petroleum Inc
188.03M
OCGN logo
OCGN
Ocugen Inc
608.82M
TRON logo
TRON
TRON Inc
359.44M
list top top 20 ai companies
Intellectia · 18 candidates
Themes: AI Beneficiary
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
good penny stocks to invest in
Intellectia · 32 candidates
Market Cap: <= 500.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 10.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAN logo
CAN
Canaan Inc
498.64M
ORGO logo
ORGO
Organogenesis Holdings Inc
487.34M
CERS logo
CERS
Cerus Corp
485.98M
OCGN logo
OCGN
Ocugen Inc
465.36M
API logo
API
Agora Inc
402.42M
NNDM logo
NNDM
Nano Dimension Ltd
395.43M
ai companies
Intellectia · 18 candidates
Themes: AI BeneficiaryWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B
what AI company's have equity divedends
Intellectia · 14 candidates
Dividend Yield Ttm: >= 0Themes: AI BeneficiaryIs Optionable: True
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.45T
MSFT logo
MSFT
Microsoft Corp
3.30T
META logo
META
Meta Platforms Inc
1.54T
MU logo
MU
Micron Technology Inc
437.95B
AMD logo
AMD
Advanced Micro Devices Inc
406.68B
PLTR logo
PLTR
Palantir Technologies Inc
394.05B

Whales Holding NNOX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nano-X Imaging Ltd (NNOX) stock price today?

The current price of NNOX is 1.91 USD — it has increased 5.52

What is Nano-X Imaging Ltd (NNOX)'s business?

Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.

What is the price predicton of NNOX Stock?

Wall Street analysts forecast NNOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NNOX is7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nano-X Imaging Ltd (NNOX)'s revenue for the last quarter?

Nano-X Imaging Ltd revenue for the last quarter amounts to 3.72M USD, increased 23.97

What is Nano-X Imaging Ltd (NNOX)'s earnings per share (EPS) for the last quarter?

Nano-X Imaging Ltd. EPS for the last quarter amounts to -0.50 USD, increased 117.39

How many employees does Nano-X Imaging Ltd (NNOX). have?

Nano-X Imaging Ltd (NNOX) has 197 emplpoyees as of May 21 2026.

What is Nano-X Imaging Ltd (NNOX) market cap?

Today NNOX has the market capitalization of 125.96M USD.